Evidence map›Paper›PMID 25595198›Full record

ArticleParasites & vectors2015

Seroprevalence of Triatoma virus (Dicistroviridae: Cripaviridae) antibodies in Chagas disease patients.

Jailson F B Querido, María G Echeverría, Gerardo A Marti, Rita Medina Costa, María L Susevich, Jorge E Rabinovich, Aydee Copa, Nair A Montaño, Lineth Garcia, Marisol Cordova and 16 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Triatomines: Trypanosomatids, Bacteria, and Viruses Potential Vectors?Frontiers in cellular and infection microbiology · 2018
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 7 countries.

Jailson F B QueridoCentre for Malaria and Tropical Diseases, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal. jailson.brito.querido@gmail.com.
María G EcheverríaCátedra de Virología, Facultad de Ciencias Veterinarias Universidad Nacional de La Plata (UNLP-CONICET), La Plata, Argentina. mariagabrielaecheverria@yahoo.com.ar.
Gerardo A MartiCentro de Estudios Parasitológicos y de Vectores (CEPAVE-CCT- La Plata -CONICET - UNLP), La Plata, Argentina. gerardomarti22@yahoo.com.ar.
Rita Medina CostaCentre for Malaria and Tropical Diseases, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal. ritamedina_costa@hotmail.com.
María L SusevichCátedra de Virología, Facultad de Ciencias Veterinarias Universidad Nacional de La Plata (UNLP-CONICET), La Plata, Argentina. mlsusevich@hotmail.com.
Jorge E RabinovichCentro de Estudios Parasitológicos y de Vectores (CEPAVE-CCT- La Plata -CONICET - UNLP), La Plata, Argentina. jorge.rabinovich@gmail.com.
Aydee CopaLaboratorio de Biología Molecular IIBISMED, Facultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia. acopa@hotmail.com.
Nair A MontañoLaboratorio de Biología Molecular IIBISMED, Facultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia. namontano@gmail.com.
Lineth GarciaLaboratorio de Biología Molecular IIBISMED, Facultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia. lineth.garcia@gmail.com.
Marisol CordovaFacultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia. mcordova@hotmail.com.
Faustino TorricoFacultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia. foxtorrico@yahoo.com.
Rubén Sánchez-EugeniaUnidad de Biofísica (UBF, CSIC, UPV-EHU), Leioa, Bizkaia, Spain. r.sanchez.eugenia@gmail.coml.
Lissete Sánchez-MagranerUnidad de Biofísica (UBF, CSIC, UPV-EHU), Leioa, Bizkaia, Spain. lissetes@hotmail.com.
Xabier Muñiz-TrabuduaUnidad de Biofísica (UBF, CSIC, UPV-EHU), Leioa, Bizkaia, Spain. xabiermt@gmail.com.
Ibai López-MarijuanUnidad de Biofísica (UBF, CSIC, UPV-EHU), Leioa, Bizkaia, Spain. ibai_87@hotmail.com.
Gabriela S Rozas-DennisDepartamento de Biología, Bioquímica y Farmacia, and Grupo Biofísica, Departamento de Física, Universidad Nacional del Sur, Bahía Blanca, Argentina. grozas@criba.edu.ar.
Patricio DiosqueUnidad de Epidemiología Molecular del Instituto de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Salta, Argentina. patricio.diosque@gmail.com.
Ana M de CastroInstituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiania, Brazil. amaria.ana@gmail.com.
Carlos RobelloUnidad de Biología Molecular Instituto Pasteur de Montevideo, Mataojo 2020, CP11400, Montevideo, Uruguay. robello@pasteur.edu.uy.
Julio S RodríguezCENPALAB, Delegación CIMTA, Santiago de Cuba, Cuba. juliocesar.neurotox@gmail.com.
Jaime AltchehParasitologia-Chagas, Hospital de Niños R. Gutierrez, Buenos Aires, Argentina. altcheh@gmail.com.
Paz M Salazar-SchettinoDepartamento de Microbiología y Parasitología, Facultad de Medicina (LBP-DMP-FM), Universidad Nacional Autónoma de México, Mexico City, DF, México. pazmar@unam.mx.
Marta I BucioDepartamento de Microbiología y Parasitología, Facultad de Medicina (LBP-DMP-FM), Universidad Nacional Autónoma de México, Mexico City, DF, México. mbucio@hotmail.com.
Bertha EspinozaDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Autónoma de México, Mexico City, DF, México. besgu@biomedicas.unam.mx.
Diego M A GuérinUnidad de Biofísica (UBF, CSIC, UPV-EHU), Leioa, Bizkaia, Spain. diego.guerin@ehu.es.
Marcelo Sousa SilvaCentre for Malaria and Tropical Diseases, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal. mssilva@ihmt.unl.pt.
Fundación Biofísica Bizkaia · ESUniversidade Nova de Lisboa · PTUniversidad Nacional Autónoma de México · MXUniversity of San Simón · BOConsejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Nacional de La Plata · ARHospital General de Niños Ricardo Gutierrez · ARInstitut Pasteur de Montevideo · UYNational University of Salta · ARUniversidade Federal de Goiás · BRUniversidad Nacional del Sur · ARUniversity of the Basque Country · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChagas disease is caused by Trypanosoma cruzi, and humans acquire the parasite by exposure to contaminated feces from hematophagous insect vectors known as triatomines. Triatoma virus (TrV) is the sole viral pathogen of triatomines, and is transmitted among insects through the fecal-oral route and, as it happens with T. cruzi, the infected insects release the virus when defecating during or after blood uptake.

methodsIn this work, we analysed the occurrence of anti-TrV antibodies in human sera from Chagas disease endemic and non-endemic countries, and developed a mathematical model to estimate the transmission probability of TrV from insects to man, which ranged between 0.00053 and 0.0015.

resultsOur results confirm that people with Chagas disease living in Bolivia, Argentina and Mexico have been exposed to TrV, and that TrV is unable to replicate in human hosts.

conclusionsWe presented the first experimental evidence of antibodies against TrV structural proteins in human sera.

Indexed as

AmericasAnimalsAntibodies, ViralChagas DiseaseDicistroviridaeEnzyme-Linked Immunosorbent AssayHumansModels, BiologicalPortugalSeroepidemiologic StudiesTriatomaViral Structural ProteinsAntibodies, ViralViral Structural Proteins

Identifiers

PMID25595198
PMCPMC4351825
OpenAlexW2122035436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.